These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36183918)

  • 21. Press-coating of immediate release powders onto coated controlled release tablets with adhesives.
    Waterman KC; Fergione MB
    J Control Release; 2003 May; 89(3):387-95. PubMed ID: 12737841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of propranolol HCl release kinetics from press coated sustained release tablets.
    Ali AA; Ali AM
    Pharm Dev Technol; 2013; 18(5):1238-46. PubMed ID: 22582904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy.
    Sawada T; Kondo H; Nakashima H; Sako K; Hayashi M
    Int J Pharm; 2004 Aug; 280(1-2):103-11. PubMed ID: 15265551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation of verapamil hydrochloride core-in-cup tablets with double-pulsatile and multi-phasic release].
    Li CJ; Zhu JB; Yu WY
    Yao Xue Xue Bao; 2008 Jun; 43(6):652-6. PubMed ID: 18822971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nifedipine di-matrix depot tablets prepared by compression coating for obtaining zero-order release.
    Liu T; Shi Y; Li J; Jiang W; Yin T; Zhang Y; He H; Wang Y; Tang X
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1426-1433. PubMed ID: 29871528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and evaluation of a zero-order controlled release system based on pre-hydrated constant release area prepared by compression coating technology.
    Wang Q; Jiao J; Cai Q; Wang Q; Zhou W
    Pharm Dev Technol; 2021 Dec; 26(10):1120-1129. PubMed ID: 34698603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting.
    Fukui E; Miyamura N; Uemura K; Kobayashi M
    Int J Pharm; 2000 Aug; 204(1-2):7-15. PubMed ID: 11011980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation approach for nicorandil pulsatile release tablet.
    Maeda H; Ogawa Y; Ishiyama M; Hirayama T; Terada K
    Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):464-7. PubMed ID: 18379091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosage form design and in vitro/in vivo evaluation of cevimeline extended-release tablet formulations.
    Tajiri S; Kanamaru T; Kamada M; Konno T; Nakagami H
    Int J Pharm; 2010 Jan; 383(1-2):99-105. PubMed ID: 19747964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the effect of coating equipment on tablet film quality using terahertz pulsed imaging.
    Haaser M; Naelapää K; Gordon KC; Pepper M; Rantanen J; Strachan CJ; Taday PF; Zeitler JA; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1095-102. PubMed ID: 23563103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
    Rujivipat S; Bodmeier R
    Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Micronized ethylcellulose used for designing a directly compressed time-controlled disintegration tablet.
    Lin SY; Lin KH; Li MJ
    J Control Release; 2001 Feb; 70(3):321-8. PubMed ID: 11182202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissolution of tablet-in-tablet formulations studied with ATR-FTIR spectroscopic imaging.
    Wray PS; Clarke GS; Kazarian SG
    Eur J Pharm Sci; 2013 Mar; 48(4-5):748-57. PubMed ID: 23291036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of Chronomodulated Drug Delivery System of Valsartan: In Vitro Characterization.
    Sokar M; Hanafy A; Elkamel A; El-Gamal S
    Indian J Pharm Sci; 2015; 77(4):470-7. PubMed ID: 26664064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compression-Coated Tablet for Colon Targeting: Impact of Coating and Core Materials on Drug Release.
    Maity S; Sa B
    AAPS PharmSciTech; 2016 Apr; 17(2):504-15. PubMed ID: 26271189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Press-Coated Aceclofenac Tablets for Pulsatile Drug Delivery: Formulation and In Vitro Evaluations.
    Rashid R; Zaman M; Ahmad M; Khan MA; Butt MH; Salawi A; Almoshari Y; Alshamrani M; Sarfraz RM
    Pharmaceuticals (Basel); 2022 Mar; 15(3):. PubMed ID: 35337124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hot-melt coating technology. I. Influence of Compritol 888 Ato and granule size on theophylline release.
    Faham A; Prinderre P; Farah N; Eichler KD; Kalantzis G; Joachim J
    Drug Dev Ind Pharm; 2000 Feb; 26(2):167-76. PubMed ID: 10697753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation of gastric retenting and chronopharmacologic drug delivery tablets of sinomenine hydrochloride].
    Zhang Y; Wu Y; Geng Y; Peng X
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(5):554-9. PubMed ID: 19526781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preperation of terbutaline sulphate pulsatile release tablet and mechanism elucidation].
    Zhang Y; Zhang ZR
    Yao Xue Xue Bao; 2003 Nov; 38(11):854-8. PubMed ID: 14992001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.